Drug Database
Back to search

Netherlands· NL-031a0e614dc9

Epidyolex 100 mg/ml, drank

A cannabidiol product containing cannabidiol, registered in Netherlands by Jazz Pharmaceuticals Ireland Limited. The same ATC class is registered in 14 of our 19 countries.

ATC N03AX24

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEpidyolex 100 mg/ml, drankATCN03AX24REGISTER NO.NL-031a0e614dc9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cannabidiolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cannabidiol is registered in 14 of 19 countries.

Countries holding a registration under ATC N03AX24 (cannabidiol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search cannabidiol products by name

Cannabidiol · ATC N03AX24

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CANNABIDIOL
Manufacturer
Jazz Pharmaceuticals Ireland Limited
Country
Netherlands (NL)
ATC code
N03AX24
ATC class
Cannabidiol
Defined daily dose
0.7 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/19/1389

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for cannabidiol.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cannabidiol against other medicinesHow interaction checks work

Cannabidiol · interactions on record

277 records

  • 4 severe
  • 251 moderate
  • 22 minor

Most severe, free to view

  • ClotrimazoleA01AB18moderate
  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cannabidiol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cannabidiol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Epidyolex
  • Liechtenstein · Epidyolex
  • Norway · Epidyolex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf5df541-22ad-4105-b93b-617102fe8e7a
GET /v1/drugs/bf5df541-22ad-4105-b93b-617102fe8e7a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/epidyolex-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Cannabidiol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp122465",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "BENZYLALCOHOL (E 1519)",
    "ETHANOL",
    "PROPYLEENGLYCOL (E 1520)",
    "SESAMOLIE, GEZUIVERD",
    "SUCRALOSE (E 955)",
    "TOCOFEROL, ALFA (OPTISCHE ROTATIE ONBEKEND)",
    "TRIETHYLCITRAAT (E 1505)"
  ],
  "substances": [
    "CANNABIDIOL"
  ],
  "leaflet_url": null,
  "authorised_at": "2019/09/19",
  "procedure_number": "EMEA/H/C/004675",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/19/1389",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about cannabidiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console